首页 › 基金 › KVP Capital Advisors, LP › MLYS
KVP Capital Advisors, LP 对 MLYS 的持仓历史
MINERALYS THERAPEUTICS INC · 医疗保健
KVP Capital Advisors, LP 在 Q3 2026 的 13F 申报中披露持有 MLYS(MINERALYS THERAPEUTICS INC)84,168 股,市值约 US$2.1M,约占其申报组合的 1.73%,在其申报持仓中市值排名第 24 位。 KVP Capital Advisors, LP 最近 2 个申报季度中有 2 个季度披露了 MLYS 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
KVP Capital Advisors, LP 对 MLYS 的持仓演变
KVP Capital Advisors, LP 于 Q2 2026 首次披露 MLYS 持仓:84,168 股(约 US$2.3M)。 在 2 次申报中,KVP Capital Advisors, LP 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 84,168 股、市值约 US$2.1M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 84.17K | $2.27M | 新进 |
| Q3 2026 | 84.17K | $2.12M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 MLYS 与 13F 数据
MLYS(MINERALYS THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 47 只申报持有 MLYS,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$207.6M), Catalys Pacific, LLC (US$196.0M), Samsara BioCapital, LLC (US$158.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 MLYS 的基金
- RA CAPITAL MANAGEMENT, L.P. 7.69M 股 · $207.55M · Q2 2026
- Catalys Pacific, LLC 7.80M 股 · $196.00M · Q3 2026
- Samsara BioCapital, LLC 5.87M 股 · $158.40M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 3.96M 股 · $106.79M · Q2 2026
- Laurion Capital Management LP 2.48M 股 · $62.37M · Q3 2026
- ORBIMED ADVISORS LLC 2.11M 股 · $56.94M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 1.56M 股 · $42.20M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.60M 股 · $40.21M · Q3 2026
- Andera Partners 1.59M 股 · $40.00M · Q3 2026
- SPHERA FUNDS MANAGEMENT LTD. 1.47M 股 · $39.66M · Q2 2026
- Ghisallo Capital Management LLC 1.12M 股 · $28.27M · Q3 2026
- Prosight Management, LP 800.00K 股 · $20.10M · Q3 2026
更多关于 KVP Capital Advisors, LP
常见问题
How long has KVP Capital Advisors, LP held MLYS?
KVP Capital Advisors, LP has disclosed MLYS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is KVP Capital Advisors, LP's current position in MLYS?
As of Q3 2026, KVP Capital Advisors, LP holds 84.17K shares of MLYS (MINERALYS THERAPEUTICS INC), valued at $2.12M, representing 1.73% of its reported portfolio and ranking #24.
Has KVP Capital Advisors, LP been buying or selling MLYS?
In the latest 13F filing (Q3 2026), KVP Capital Advisors, LP held unchanged its position in MLYS.
Which other funds hold MLYS?
Other major institutional holders of MLYS include RA CAPITAL MANAGEMENT, L.P., Catalys Pacific, LLC, Samsara BioCapital, LLC, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.